BioEcho Life Sciences introduces the EchoLUTION™ Tissue RNA Kit for rapid and reliable RNA extraction without phenol/chloroform

The EchoLUTION Tissue RNA Kit: 50 reactions in spin column format. (Copyright: BioEcho Life Sciences GmbH)

BioEcho Life Sciences, the biotechnology company offering rapid and sustainable technologies for nucleic acid extraction, has launched its latest product: the EchoLUTION Tissue RNA Kit – developed for optimized total RNA extraction from mammalian tissue, including challenging tissues such as muscles.

"We are very pleased to introduce the EchoLUTION Tissue RNA Kit," said Christiane Schlottbom, Director of Marketing at BioEcho Life Sciences. "This innovative solution represents a significant advance in RNA extraction technology and offers researchers unparalleled speed, efficiency, and reliability in their experiments. We are confident that the EchoLUTION Tissue RNA Kit will greatly simplify the workflows of scientists working in various areas of molecular biology, as it delivers high-quality RNA without the need for phenol/chloroform."

The EchoLUTION Tissue RNA Kit offers numerous advantages over conventional methods and provides researchers with flexibility and versatility. The kit is suitable for a variety of freshly frozen or stabilized tissues. The product significantly reduces the required time and increases laboratory efficiency. The one-step purification combined with ultrafast tissue lysis enables complete extraction of 96 samples within 35 minutes. The result is high-purity RNA free from contaminants and inhibitors, ensuring reliable and reproducible results in downstream applications such as RT-qPCR and RNA-seq.

Furthermore, the EchoLUTION Tissue RNA Kit underscores BioEcho's commitment to sustainability and environmentally conscious practices, as it uses up to 50% less plastic compared to other extraction methods and no longer requires hazardous reagents.